A Study of LUCAR-DKS1 in Subjects With Relapsed/Refractory Autoimmune Diseases
Clinical trial NCT07095075 · RECRUITING
Trial details
- NCT number
- NCT07095075
- Sponsor
- Nanjing Legend Biotech Co.
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-14
- Primary completion
- 2029-12-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.